US life sciences firm LumiraDx, who make rapid Covid-19 tests and are based at Manor Farm Business Park will invest in their local Stirling operation. 510 jobs will be created over the next three years, with the potential to increase to 750, after the company announced a £78million investment in its Scottish operation.
The posts will be located at sites across Stirling, Inverness and a new facility to be built at Eurocentral near Glasgow.
The jobs will help scale up manufacturing, as well as the development of other tests for other conditions.
LumiraDx chief executive Ron Zwanziger hailed a £15 million grant from Scottish Enterprise to help with the expansion. Mr Zwanziger said: “Implementing reliable Covid-19 diagnostic testing programs, that provide rapid results with minimum false negatives is critical to safely reopening the economy.
“We are pleased to contribute to Scotland’s health and economic growth, now and beyond the pandemic. We are also delighted to be increasing our footprint in Scotland and expanding the country’s life sciences industry. Next generation point of care testing technology can help to transform healthcare systems. It’s an exciting undertaking, and we know to do this quickly and to do it well we need the right infrastructure in place and access to incredible talent to drive this development. Scotland has both. We are proud to be investing in the country, and its communities and grateful to Scottish Enterprise for their support through this grant.”
Stirling Council chief executive, Carol Beattie, said: “Stirling’s reputation as a prime location for attracting new investment is growing every day, and today’s news is another welcome announcement from one of the many valued businesses in the life sciences sector in our City.”
Support your local newspaper